Evidence map›Paper›PMID 38688242›Full record

Trial reportPsychotherapy and psychosomatics2024

Enhanced Skills Training in Affective and Interpersonal Regulation versus Treatment as Usual for ICD-11 Complex PTSD: A Pilot Randomised Controlled Trial (The RESTORE Trial).

Thanos Karatzias, Mark Shevlin, Marylène Cloitre, Walter Busuttil, Katherine Graham, Laura Hendrikx, Philip Hyland, Natasha Biscoe, Dominic Murphy

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Psychotherapy and psychosomatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Navigating the landscape of trauma treatments: the need for personalized care.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2025
    Article
  12. The promise of ICD-11-defined PTSD and complex PTSD to improve care for trauma-exposed populations.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2025
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Thanos KaratziasSchool of Health and Social Care, Edinburgh Napier University, Edinburgh, UK.
Mark ShevlinSchool of Psychology, Ulster University, Northern Ireland, UK.
Marylène CloitreNational Center for PTSD Dissemination and Training Division, VA Palo Alto Health Care System, Palo Alto, California, USA.
Walter BusuttilResearch Department, Combat Stress, Surrey, UK.
Katherine GrahamResearch Department, Combat Stress, Surrey, UK.
Laura HendrikxResearch Department, Combat Stress, Surrey, UK.
Philip HylandDepartment of Psychology, Maynooth University, Kildare, Ireland.
Natasha BiscoeResearch Department, Combat Stress, Surrey, UK.
Dominic MurphyNational Center for PTSD Dissemination and Training Division, VA Palo Alto Health Care System, Palo Alto, California, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionComplex PTSD (CPTSD) is a relatively new condition in ICD-11. This pilot randomised controlled trial aimed to compare a four-module intervention developed to target all symptoms of ICD-11 CPTSD, namely Enhanced Skills in Affective and Interpersonal Regulation (ESTAIR) with treatment as usual (TAU). The purpose of the study was to assess feasibility, safety, acceptability, and preliminary outcomes at the end of treatment and 3-month follow-up.

methodsA total of N = 56 eligible veterans with CPTSD were randomised to either ESTAIR (n = 28) or TAU (n = 28). Linear mixed models were conducted to assess CPTSD severity, the primary outcome, as measured by the International Trauma Questionnaire (ITQ).

resultsTreatment dropout in ESTAIR and TAU was low and equivalent (18% vs. 11%; χ2 (1) = 1.19, p = 0.275), and study retention was high, supporting the feasibility of the study. No serious adverse effects and very few adverse effects occurred, none of which were deemed related to the study. ESTAIR provided significantly greater reduction in CPTSD severity across time for ITQ PTSD (p < 0.001) and DSO (p < 0.001) symptoms. CPTSD pre-to-post effect sizes for ESTAIR were large (PTSD d = 1.78; DSO d = 2.00). Remission of probable CPTSD diagnosis at post-treatment was substantially greater in ESTAIR compared to TAU with only 13.6% versus 84% (p < 0.001) retaining the diagnosis.

conclusionA trial of ESTAIR versus TAU for the treatment of ICD-11 CPTSD indicates the potential efficacy of ESTAIR as well as its feasibility, safety, and acceptability.

Indexed as

Stress Disorders, Post-TraumaticVeteransAdultFeasibility StudiesFemaleHumansInternational Classification of DiseasesInterpersonal RelationsMaleMiddle AgedPilot ProjectsTreatment OutcomeComplex PTSDEstairRCT

Identifiers

PMID38688242
PMCPMC11152001

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.